Second-Line Chemotherapy in Recurrent Glioblastoma: A 2-Cohort Study

Publisher： Karger

E-ISSN： 2296-5262|38|7-8|348-354

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.38, Iss.7-8, 2015-06, pp. : 348-354

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Second-Line Chemotherapy in Recurrent Glioblastoma - Still Controversial

By  

Oncology Research and Treatment, Vol. 38, Iss. 7-8, 2015-07 ,pp. : 345-346

Karger

Access to resources Recommend Favorite

Is Gemcitabine plus Vinorelbine Active in Second-Line Chemotherapy of Metastatic Breast Cancer? A Single-Center Phase 2 Study

By  

Oncology, Vol. 64, Iss. 4, 2003-05 ,pp. : 479-480

Karger

Access to resources Recommend Favorite

Cardiovascular risks associated with second‐line oral antidiabetic agents added to metformin in patients with Type 2 diabetes: a nationwide cohort study

By  

DIABETIC MEDICINE, Vol. 32, Iss. 11, 2015-11 ,pp. : 1460-1469

John Wiley & Sons Inc

Access to resources Recommend Favorite

Relevance and Necessity of Studies on Second-Line Chemotherapy in Melanoma

By  

Oncology Research and Treatment, Vol. 27, Iss. 6, 2004-12 ,pp. : 527-528

Karger

Access to resources Recommend Favorite

Second-Line Chemotherapy in Advanced Bladder Cancer

By  

Urologia Internationalis, Vol. 64, Iss. 2, 2000-05 ,pp. : 61-69

Karger

Access to resources Recommend Favorite